Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.

Introduction: Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella-zoster virus infections. In this article we summarize the findings of four phase 1 studies in healthy participants.Methods: Four randomized phase 1 studies investigated the safety...

Descripción completa

Detalles Bibliográficos

Publicado en:	Advances in Therapy Vol. 34; no. 12; pp. 2625 - 2638
Autores principales:	Kusawake, Tomohiro, Keirns, James, Kowalski, Donna, den Adel, Martin, Groenendaal-van de Meent, Dorien, Takada, Akitsugu, Ohtsu, Yoshiaki, Katashima, Masataka, Keirns, James J
Formato:	clinical trial research randomized controlled trial Journal Article
Publicado:	Springer Nature Dec2017
Acceso en línea:	Ver este registro en EBSCOhost